These findings identify a D1-MSN ER stress response that promotes cocaine-induced neuroadaptations via the ATF4–SPTLC1 signaling axis and suggest a potential therapeutic target for cocaine addiction. The gene discussed is ATF4; the disease is cocaine dependence.